|
|
TRIAL
|
PHASE
|
STATUS
|
PATIENT PROFILE
|
COUNTRIES
|
PUBLICATIONS
|
|
|
|
|
|
|
| TMC278-C201 |
IIa |
Completed |
ARV* treatment-naïve HIV-1 infected subjects |
Germany, Russia, UK |
 |
| TMC278-C202 |
IIa |
Completed |
1st line treatment failures |
Austria, France, Germany, Italy, Russia, UK |
|
|
|
|
|
|
|
|
TMC278-C204
|
IIb |
Ongoing |
ARV* treatment-naïve HIV-1 infected subjects |
Argentina, Austria, Brazil, China, France, Germany, Mexico, Russia, South Africa, Thailand, Uganda, UK, USA |
Manuscript in AIDS
|
|
|
|
|
|
|
|
TMC278-C209
|
III |
Ongoing |
ARV* treatment-naïve HIV-1 infected subjects |
Argentina, Austria, Australia, Brazil, Canada, Denmark, Spain, France, Great Britain, India, Italy, Mexico, The Netherlands, Puerto Rico, Portugal, Romania, Russia, Sweden, Thailand, Taiwan, USA, South Africa |
|
|
TMC278-C215
|
III |
Ongoing |
ARV* treatment-naïve HIV-1 infected subjects |
Argentina, Australia, Belgium, Brazil, Canada, Chile, Costa Rica, Germany, Spain, France, Great Britain, India, Italy, Mexico, Panama, Puerto Rico, Portugal, Russia, Thailand, USA, South Africa |
|
|
ARV* = antiretroviral
|
|
